Overall rank by patents
#3,257
Across all tracked assignees
USPTO PatentsView assignee record - 115 granted patents across 44 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
Institut holds 115 US patents across 44 technology areas, rank #3,257 of 50,000 tracked assignees.
Institut Curie has been granted 115 US utility patents between 2015 and 2025, placing Institut Curie at rank #3,257 across all assignees tracked by PlainPatent. This portfolio spans 44 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.2 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Institut Curie is one of the more focused assignees in the PatentsView dataset. By volume, Institut sits between Deutsches Krebsforschungszentrum (115 patents, rank #3,253) and National Taiwan Normal University (115 patents, rank #3,261) - the closest US assignees by grant volume. The composite Innovation Score of 51.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 60 grants, compared with 55 in the 2015–2019 window, a +9% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Institut Curie's 15.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 44 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Institut Curie against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Deutsches Krebsforschungszentrum
115 patents
Dresser, LLC
115 patents
HISAMITSU PHARMACEUTICAL CO., INC.
115 patents
Hunter Engineering Company
115 patents
MESSIER-BUGATTI-DOWTY
115 patents
MINKA LIGHTING, INC.
115 patents
MITSUBISHI HEAVY INDUSTRIES ENGINEERING, LTD.
115 patents
National Taiwan Normal University
115 patents
INSTITUT CURIE
115 patents
What this shows Institut holds 115 patents at rank #3,257, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,257 in granted patent volume.
Other assignees with the most granted patents in Institut's primary technology class.
Institut's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
52 Top 11% higher than 89% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 10 | 8.7% |
| 2016 | 10 | 8.7% |
| 2017 | 14 | 12.2% |
| 2018 | 14 | 12.2% |
| 2019 | 7 | 6.1% |
| 2020 | 19 | 16.5% |
| 2021 | 15 | 13.0% |
| 2022 | 8 | 7.0% |
| 2023 | 4 | 3.5% |
| 2024 | 4 | 3.5% |
| 2025 | 10 | 8.7% |
Top 15 of 44 technology areas
Overall rank by patents
#3,257
Across all tracked assignees
51.6 out of 100
How to use this portfolio
Institut's 115 grants land it in the top 11% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.